Embryonic stem cells improve skeletal muscle recovery after extreme atrophy in mice

Muscle Nerve. 2015 Mar;51(3):346-52. doi: 10.1002/mus.24320. Epub 2015 Jan 7.

Abstract

Introduction: We injected embryonic stem cells into mouse tibialis anterior muscles subjected to botulinum toxin injections as a model for reversible neurogenic atrophy.

Methods: Muscles were exposed to botulinum toxin for 4 weeks and allowed to recover for up to 6 weeks. At the onset of recovery, a single muscle injection of embryonic stem cells was administered. The myofiber cross-sectional area, single twitch force, peak tetanic force, time-to-peak force, and half-relaxation time were determined.

Results: Although the stem cell injection did not affect the myofiber cross-sectional area gain in recovering muscles, most functional parameters improved significantly compared with those of recovering muscles that did not receive the stem cell injection.

Conclusions: Muscle function recovery was accelerated by embryonic stem cell delivery in this durable neurogenic atrophy model. We conclude that stem cells should be considered a potential therapeutic tool for recovery after extreme skeletal muscle atrophy.

Keywords: atrophy; botulinum toxin; contractile function; embryonic stem cells; skeletal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Botulinum Toxins / toxicity
  • Embryonic Stem Cells / transplantation*
  • Humans
  • Male
  • Mice
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiology*
  • Muscular Atrophy / chemically induced
  • Muscular Atrophy / pathology
  • Muscular Atrophy / therapy*
  • Recovery of Function / physiology*
  • Stem Cell Transplantation / methods*

Substances

  • Botulinum Toxins